The Lingering Scars: A Year After DOGE Cuts, Former FDA Professionals Grapple with Abandoned Missions

One year after the Department of Government Efficiency (DOGE) initiated sweeping budget cuts at the Food and Drug Administration, the human cost is becoming clear. Through interviews with six former agency professionals, Nova Global News explores the profound consequences of these austerity measures, including the termination of critical clinical trials and the abandonment of essential public health initiatives. Beyond the immediate fiscal impact, these former staffers describe a crisis of professional identity, noting how the loss of institutional memory and the departure of veteran scientists have left the agency in a state of risk-averse stagnation. The report details the cultural shift within the FDA, where fear and instability have replaced the long-standing mission of public service. As the agency grapples with the long-term ramifications of these policies, questions remain regarding the sustainability of current regulatory oversight and the potential risks to future public health security in an increasingly complex medical landscape.